Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-03-25 | 2021-04-01 | 136300 |
| TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-19 | 2023-07-05 | 195600 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2020-09-24 | 2020-10-01 | 124953 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195795 |
| TEVA-ECTOSONE | 0.1% | CREAM | Actual shortage | 2025-08-08 | 2025-10-30 | 264769 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-04-27 | 2023-07-06 | 190767 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2025-01-09 | 2025-04-29 | 247357 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2020-05-01 | 2020-06-11 | 113782 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Actual shortage | 2025-05-15 | 2025-05-15 | 257505 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195858 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Actual shortage | 2025-01-23 | 2025-01-23 | 248436 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116678 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107961 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Actual shortage | 2026-01-15 | 2026-01-22 | 276245 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2025-06-13 | 2025-08-08 | 260257 |
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125500 |
| TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-08-01 | 2017-10-10 | 17887 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |